NST-1024

N/A

Report date: 2023/06/06 20:00:40
NME

Base Information

Drug NameNST-1024
Drug Alias NameSEFA-1024
ClassificationSmall molecules
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsHypertriglyceridemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNorthsea Therapeutics Bv
China Registration ClassN/A

Develop Information

Active CompaniesNorthsea Therapeutics Bv
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A